JKN 2306
Alternative Names: JKN-2306Latest Information Update: 23 Feb 2026
At a glance
- Originator Joincare Pharmaceutical
- Class Analgesics
- Mechanism of Action Nav1.8 voltage-gated sodium channel inhibitors
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Acute pain